Stock Charts

Royal Princess Sets Sail Refreshed Ever imagine what goes on behind the scenes of a full-blown ship makeover? Well, the Royal Princess just strutted out of a two-week stint in the drydock like a queen in a new frock. This ain't just slapping a fresh coat of paint on the hull. We're talking the debut of the Sanctuary Collection, a whole new gamut of spots for guests to wet...

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

Another Chapter in Chromatography: What's New? It's like this: membrane chromatography is getting its day in the sun, and it's about time we dive into why it's happening. Projected to scale up from $0.37 billion in 2026 to a neat $0.63 billion by 2031, we’re talking a solid 11.3% compound annual growth rate. It's a tale of tech advancements and rising demand for...

Humble Bundle Lends a Hand to Kidney Health There's something heartening in the way gaming and charity collide, especially when it comes down in favor of public health. Humble Bundle's latest charitable endeavor, the "Phunkier Physics" bundle, ropes in funds to battle kidney disease, a villain in its own right that affects millions. The initiative runs till November 13,...

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

A New Spin on Nostalgia Let's chew the fat on this little number out of Tucson, Arizona. "GRUNGE," a short suspense horror film, is pulling 90s grunge music up by its Doc Martens and hurling it into a world of psychedelic chaos. Set in 1993, this flick isn't just a trip down memory lane. It's a creative whirlwind leveraging the gritty vibe of the grunge scene to wade into...

Hims & Hers Under Fire: Act Now or Pay Later If you're holding $HIMS shares, let me tell you—this isn't the time to snooze. With a federal lawsuit breathing down its neck, Hims & Hers Health, Inc. finds itself teetering on the precipice of serious financial and legal mayhem. The clock's ticking with the class action cutoff looming on November 2, 2026. If you're nursing...

Breaking the Fear of the Dentist's Chair There's no sugar-coating it—hitting the dental chair can feel like gearing up for a bout in the boxing ring, especially if anxiety's already taken root. But listen, it doesn't have to be that way, and that's where HelloNation's recent feature steps in. Dr. Adriane Lippian and Dr. Jim Lippian, dentists hailing from Texarkana,...

Amid the ever-turbulent waves of industrial demand and environmental expectations, Novelis Inc. is set to lay bare its fiscal cards for Q2 of 2027. Circle November 5 on your calendar—this is when Steve Fisher and Dev Ahuja aim to sift through the heaps, scrutinize numbers, and spell out their game plan for investors via a conference call. Get your coffee ready for this...

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...

Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....

Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...

Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...